Delayed administration of pyroglutamate helix B surface peptide (pHBSP), a novel nonerythropoietic analog of erythropoietin, attenuates acute kidney injury.

Molecular medicine (Cambridge, Mass.)

Volumn 18, Issue , 2012, Pages 719-727

  Patel, Nimesh S A ^a   Kerr Peterson, Hannah L ^b   Brines, Michael ^b   Collino, Massimo ^b   Rogazzo, Mara ^b   Fantozzi, Roberto ^b   Wood, Elizabeth G ^b   Johnson, Florence L ^b   Yaqoob, Muhammad M ^b   Cerami, Anthony ^b   Thiemermann, Christoph ^b  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLUSTERIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OLIGOPEPTIDE; OSTEOPONTIN; PROTEIN KINASE B; PYROGLUTAMATE HELIX B SURFACE PEPTIDE;

ACUTE KIDNEY FAILURE; ANIMAL; ARTICLE; BLOOD; DRUG EFFECT; GLOMERULUS; KIDNEY TUBULE; MALE; METABOLISM; PATHOPHYSIOLOGY; PROTEIN TRANSPORT; RAT; TIME; WISTAR RAT;

ACUTE KIDNEY INJURY; ANIMALS; CLUSTERIN; GLYCOGEN SYNTHASE KINASE 3; KIDNEY GLOMERULUS; KIDNEY TUBULES; MALE; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE III; OLIGOPEPTIDES; OSTEOPONTIN; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, WISTAR; TIME FACTORS;

MLCS; MLOWN;

EID: 84873522898     PISSN: None     EISSN: 15283658     Source Type: Journal    
DOI: 10.2119/molmed.2012.00093     Document Type: Article

References (0)